Hologic, a Bedford, Mass.-based manufacturer of diagnostic and imaging equipment, reported that revenue rose 6.6% to $652.8 million in its fiscal first quarter with each of its businesses reporting growth.
Net income was $111.6 million in the first quarter of fiscal 2015, up from $94.1 million in 2014.
Revenue in Hologic's breast health business increased 6.9% to $242 million in the first quarter, driven by a boost in breast imaging and service revenue as an increasing number of healthcare providers purchased three-dimensional mammography systems.
Hologic was the first company to receive approval from the Food and Drug Administration to market its 3D mammography system. The market for 3D mammography, which is also called tomosynthesis, is growing. The CMS this month started covering breast-cancer screenings using the newer systems if they are used along with traditional mammography. GE Healthcare last year began the second company to sell this technology in the U.S.
Hologic raised its full-year guidance for the year, saying it expects revenue between $2.57 billion and $2.60 billion, up from between $2.54 billion and $2.57 billion.
Follow Jaimy Lee on Twitter: @MHjlee
